Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,014 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.

NCT01996319

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Heidelberg, Germany
  • Novartis Investigative Site Potsdam, Germany
  • Novartis Investigative Site Teterow, Germany
  • Novartis Investigative Site Koblenz, North Rhine-Westphalia, Germany
View all 30 locations
View Trial Details
Completed

Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions

NCT02248909

Conditions
COPD, Chronic Disease, Disease Attributes, +6 more
Locations
  • Research Site Barnaul, Nis-rru-xxx-2014/2, Russia
  • Research Site Blagoveshchensk, Nis-rru-xxx-2014/2, Russia
  • Research Site Chelyabinsk, Nis-rru-xxx-2014/2, Russia
  • Research Site Cherepovets, Nis-rru-xxx-2014/2, Russia
View all 22 locations
View Trial Details
Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

NCT01682863

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Vestavia Hills, Alabama, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Lakewood, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 86 locations
View Trial Details
Completed

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

NCT01727141

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Montgomery, Alabama, United States
  • Novartis Investigative Site Mesa, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
View all 143 locations
View Trial Details

Related conditions